L. Becker Hewes's Trading History
| DMRADamora Therapeutics | Jan 07, 2026 | Chief Medical Officer | Uninformative Buy | ― | $5.69M | |
| BPMCBlueprint Medicines | Jul 21, 2025 | ― | Uninformative Sell | ― | $0.00 |
You May Also Like
L. Becker Hewes insider profile FAQ
What is the percentage of profitable transactions made by L. Becker Hewes?
The percentage of profitable transactions made by L. Becker Hewes is 67%.
What is the average return per transaction made by L. Becker Hewes?
The average return per transaction made by L. Becker Hewes is -18.70%.
What stocks does L. Becker Hewes hold?
L. Becker Hewes holds: DMRA, BPMC stocks.
What was L. Becker Hewes's most profitable transaction?
L. Becker Hewes’s most profitable transaction was an Informative Sell of BPMC stock on September 17, 2021. The return on the trade was 34.60%.
What is L. Becker Hewes's role in Damora Therapeutics?
L. Becker Hewes's role in Damora Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.